文献速递病毒性肝炎艾滋病与性传播感染

西班牙直接抗病毒药物免费可及:对高教育程度人群丙型肝炎死亡率影响更有利

Free Access to Direct-Acting Antivirals in Spain: More Favorable Impact on Hepatitis C Mortality Among Highly Educated People.
PubMed 文献 · Clin Infect Dis · 2023-01-01

该研究分析2012-2019年西班牙≥25岁人群丙型肝炎相关死亡率,按教育程度分层。直接抗病毒药物(DAA)免费普及后,各教育水平丙型肝炎死亡率均下降,但高教育程度人群下降更快,相对不平等指数从2.1升至2.7,提示即使在全民免费医疗体系下高教育程度者似乎获益更多。

要点

  • DAA免费普及后,低、中、高教育程度人群丙型肝炎死亡率分别从25.2、23.2、20.3/百万人年降至15.8、13.7、10.4/百万人年。
  • 干预后各教育水平丙型肝炎死亡率下降趋势均加速,但高教育程度人群加速更明显,相对不平等指数从2.1升至2.7。
  • 其他分析死因中,仅高教育程度人群的肝硬化、肝细胞癌、HIV疾病和酒精相关肝病死亡率趋势出现有利变化。

核心结论

  • 结果提示DAA治疗对所有教育水平的丙型肝炎死亡率均有非常有利的影响,但即使在全民免费医疗体系下,高教育程度人群似乎比低教育程度人群从DAA治疗中获益更多。

研究设计与样本

  • 分析2012-2019年居住在西班牙、年龄≥25岁人群的丙型肝炎、未特指肝硬化、肝细胞癌、酒精相关肝病、其他肝病和HIV疾病死亡。
  • 按时期、性别和教育程度计算每百万人年年龄标化死亡率,使用准泊松分段回归模型估计干预前后各教育水平的年百分比变化和相对不平等指数(RII)。

主要发现

  • 低、中、高教育程度人群丙型肝炎死亡率从干预前的25.2、23.2、20.3/百万人年降至干预后的15.8、13.7、10.4/百万人年。
  • 其他分析死因的死亡率也下降。
  • 干预后所有教育水平丙型肝炎死亡率下降趋势均加速,但高教育程度人群加速更明显,RII从2.1升至2.7。
  • 其他分析死因中,除高教育程度人群的肝硬化、肝细胞癌、HIV疾病和酒精相关肝病外,未观察到死亡率趋势的有利变化。

关键数值与推荐

  • 低教育程度人群丙型肝炎死亡率:干预前25.2/百万人年 vs 干预后15.8/百万人年。
  • 中教育程度人群丙型肝炎死亡率:干预前23.2/百万人年 vs 干预后13.7/百万人年。
  • 高教育程度人群丙型肝炎死亡率:干预前20.3/百万人年 vs 干预后10.4/百万人年。
  • 相对不平等指数(RII)从干预前2.1升至干预后2.7。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In 2015, hepatitis C treatment with direct-acting antivirals (DAAs) became free and widespread in Spain, significantly reducing hepatitis C-related mortality. However, health interventions can sometimes widen health inequalities. The objective of this study is to assess the impact of DAA treatment on hepatitis C-related mortality by educational level. METHODS: We analyzed deaths from hepatitis C, unspecified liver cirrhosis, hepatocellular carcinoma, alcohol-related liver diseases, other liver diseases, and human immunodeficiency virus (HIV) disease among individuals living in Spain during 2012-2019 and aged ≥25 years. We calculated age-standardized mortality rates per million person-years by period, sex, and education. Using quasi-Poisson segmented regression models, we estimated the annual percent change in rates in pre- and postintervention periods by education level and the relative inequality index (RII). RESULTS: Hepatitis C mortality rates among low, middle, and highly educated people decreased from 25.2, 23.2, and 20.3/million person-years in the preintervention period to 15.8, 13.7, and 10.4 in the postintervention period. Mortality rates from other analyzed causes also decreased. Following the intervention, downward trends in hepatitis C mortality accelerated at all education levels, although more in highly educated people, and the RII increased from 2.1 to 2.7. For other analyzed causes of death, no favorable changes were observed in mortality trends, except for liver cirrhosis, hepatocellular carcinoma, HIV disease, and alcohol-related liver disease among higher educated people. CONCLUSIONS: Results suggest that DAA treatments had a very favorable impact on hepatitis C mortality at all education levels. However, even in a universal and free healthcare system, highly educated people seem to benefit more from DAA treatment than less educated people.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Politi J, Regidor E, Donat M, et al. Free Access to Direct-Acting Antivirals in Spain: More Favorable Impact on Hepatitis C Mortality Among Highly Educated People. Clin Infect Dis. 2023. PMID: 36471910. doi:10.1093/cid/ciac928

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。